Presentation is loading. Please wait.

Presentation is loading. Please wait.

Public Health Genomics 2012;15:1–10 - DOI: /

Similar presentations


Presentation on theme: "Public Health Genomics 2012;15:1–10 - DOI: /"— Presentation transcript:

1 <i>HER2</i> Evaluation and Its Impact on Breast Cancer Treatment Decisions
Public Health Genomics 2012;15:1–10 - DOI: / Fig. 1. Rate of HER2 testing at KPNW from 1998 to The solid lines correspond to patients diagnosed with invasive breast cancer with Medicare/Medicaid insurance (diamonds) or with other insurance (circles), and the dashed lines correspond to patients diagnosed with ductal carcinoma in situ or noninvasive breast cancer. © 2011 S. Karger AG, Basel - CC BY-NC 3.0


Download ppt "Public Health Genomics 2012;15:1–10 - DOI: /"

Similar presentations


Ads by Google